◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Noile-Immune Biotech Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023
+Operating Income -1.1B -775.4M
Operating Margin % 111.1% 68.8%
Non Operating Income 107.5M 50,000
Non Operating Expenses 381,000 352.3M
+Ordinary Income -962.0M -1.1B
Revenue Growth % 14.7% --
Income Before Taxes -962.0M -1.1B
Income Taxes 2.4M 2.4M
+Net Income -964.5M -1.1B
Net Margin % 100.3% 100.2%
Eps -22.28 -27.25
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023
Cash And Deposits 4.7B 5.6B
Current Assets 4.8B 5.7B
Noncurrent Assets 24.8M 61.9M
Total Assets 4.8B 5.8B
Current Liabilities 69.4M 86.3M
Total Liabilities 74.7M 91.5M
Retained Earnings -3.4B -2.4B
Total Equity 4.7B 5.7B
Equity Ratio 0.98 0.98
Book Value Per Share 108.97 131.26
Num Employees 25.00 28.00
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023
Operating Cash Flow -887.8M -873.1M
Investing Cash Flow 557,000 -5.3M
Financing Cash Flow 2.5M 1.9B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...